DocScrib
How it WorksPricingBlog
Sign InSign UpBook a Demo
DocScrib

AI-powered medical documentation platform streamlining healthcare workflows through intelligent transcription and clinical note generation.

Book a Demo

Product

  • Medical Templates
  • Pricing
  • Integrations
  • Security & Compliance

Resources

  • Blog
  • Documentation
  • Case Studies

Contact

  • support@docscrib.com
  • +1 (555) 123-4567
  • 123 Healthcare Blvd
    Medical District, CA 90210
© 2025 DocScrib. All rights reserved.
Privacy PolicyTerms of ServiceCookie Policy
Home/Diagnosis/ICD-10 Coding for Prostate-Derived Factor Biomarkers

ICD-10 Coding for Prostate-Derived Factor Biomarkers

C61
R97.21

Complete ICD-10-CM coding and documentation guide for icd-10 coding for prostate-derived factor biomarkers includes clinical validation requirements, medical necessity guidelines, and coding policies.

Also Known as:
PDEF
Prostate-Derived Ets Transcription Factor
PrDGF
Join 10,000+ Happy Clinicians

The AI Medical Scribe for Happiest Clinicians

Save 2+ hours daily with instant clinical documentation.
Our AI scribe listens, understands, and generates comprehensive medical notes so you can focus on patient care.

Start Free Trial
No credit card required•HIPAA compliant
Recording Controls
Start recording to see live transcription
Live Conversation - Try For Free!
Real-time transcription with automatic speaker identification

Ready to Record

Start recording to see live conversation transcription

Key Information: ICD-10 Coding for Prostate-Derived Factor Biomarkers

Essential facts and insights about ICD-10 Coding for Prostate-Derived Factor Biomarkers

Use ICD-10 code C61 for malignant neoplasm of prostate, ensuring proper documentation in clinical notes.

Primary ICD-10-CM Codes

Malignant neoplasm of prostate

Billable Code
C61
Billable

Diagnostic Criteria

  • • Confirmed prostate cancer with PDEF overexpression

Applicable To

  • • Prostate cancer

Important Notes

  • • Ensure PDEF involvement is clearly documented.

Rising PSA following treatment for malignant neoplasm of prostate

Billable Code
R97.21
Billable

Diagnostic Criteria

  • • Documented rise in PSA levels post-treatment
  • • PDEF expression noted

Applicable To

  • • Biochemical recurrence

Important Notes

  • • Ensure PSA levels and PDEF are documented.
Ancillary Codes

Additional codes that may be used with this diagnosis

Z17.2

Estrogen receptor positive status

Use when PDEF is linked to ER+ tumors.

Frequently Asked Questions

What are the ICD-10 guidelines for prostate-derived factors?

ICD-10 guidelines for prostate-derived factors involve coding prostate cancer with PDEF involvement using C61, and documenting PDEF expression and ER status.

How does PDEF affect prostate cancer coding?

PDEF affects prostate cancer coding by requiring documentation of its expression and linking it to codes like C61 and Z17.2 for accurate representation.

Quick Navigation
All DiagnosesICD-10 Codes

Related Resources

How Medical Coding WorksBrowse All Codes